Loading
IARC estimates 4,011 new cancer cases and 2,284 cancer deaths in Trinidad and Tobago in 2024; the commonest new cancers are prostate, breast and colorectum. This page is assembled automatically from OnCo's data, and says what OnCo does not yet hold.
| Site | New cases | Rate | OnCo page |
|---|---|---|---|
| Prostate | 793 | 73.4 | Prostate cancer |
| Breast | 654 | 54.8 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 429 | 17.9 | Colorectal cancer |
| Trachea, bronchus and lung | 278 | 11.4 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Corpus uteri | 244 | 18.7 | Endometrial cancer |
| Cervix uteri | 193 | 17.1 | Cervical cancer |
| Ovary | 133 | 10.8 | Ovarian cancer |
| Pancreas | 130 | 5.3 | Pancreatic ductal adenocarcinoma |
| Non-Hodgkin lymphoma | 104 | 4.6 | Non-Hodgkin lymphoma (all types), Diffuse large B-cell lymphoma |
| Multiple myeloma | 91 | 3.7 | Multiple myeloma |
| Site | Deaths | Rate | OnCo page |
|---|---|---|---|
| Prostate | 342 | 35.9 | Prostate cancer |
| Breast | 284 | 22.5 | Triple-negative breast cancer (TNBC), HR-positive / HER2-negative breast cancer, HER2-positive breast cancer |
| Colorectum | 253 | 10.4 | Colorectal cancer |
| Trachea, bronchus and lung | 226 | 9.2 | Lung cancer (all types), Non-small-cell lung cancer, Small-cell lung cancer |
| Pancreas | 119 | 4.8 | Pancreatic ductal adenocarcinoma |
| Cervix uteri | 112 | 9.0 | Cervical cancer |
| Corpus uteri | 102 | 7.3 | Endometrial cancer |
| Ovary | 96 | 7.5 | Ovarian cancer |
| Multiple myeloma | 62 | 2.5 | Multiple myeloma |
| Leukaemia | 61 | 2.8 | Acute myeloid leukaemia, Acute lymphoblastic leukaemia, Chronic lymphocytic leukaemia |
No trial record in OnCo lists a site in Trinidad and Tobago. OnCo reads sites from ClinicalTrials.gov; studies registered only elsewhere are searchable through the WHO International Clinical Trials Registry Platform.
OnCo holds no institution, company or person in Trinidad and Tobago.
OnCo records approvals for United States, European Union, United Kingdom, Japan, China, Australia and India. Trinidad and Tobago is not one of them, so no approval in OnCo speaks for it. See the approvals by region matrix for what is held.
Trinidad and Tobago is not among the 60 countries ranked in the country coverage queue (November 2026), which ranks countries without a page by cases, deaths, research output and population. Know a source? Suggest an edit.